Diseases and Conditions
- Appendiceal Cancer
- Colorectal Cancer
- Gastric Cancer
- Peritoneal Mesothelioma
- Peritoneal Surface Malignancies
Treatments and Services
- Laparoscopic Surgery
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- Robotic Assisted Laparoscopy
Patients Ages Seen
- Froedtert Hospital – Milwaukee
- Complex General Surgical Oncology
Ugwuji N. Maduekwe, MD, MMSc, MPH, FACS is currently Associate Professor of Surgery and Director of Regional Therapies in the Division of Surgical Oncology, Department of Surgery at the Medical College of Wisconsin. Dr. Maduekwe received her undergraduate degree from The University of Texas at Dallas and her MD from Harvard Medical School. She completed her general surgery residency at the Massachusetts General Hospital in Boston followed by a Complex General Surgical Oncology fellowship at The University of Pittsburgh Medical Center. Her clinical practice is focused on the management of peritoneal surface malignancies and gastrointestinal malignancies.
Maduekwe is a member of several prestigious societies including the American College of Surgeons, the Society of Surgical Oncology, Society of Black Academic Surgeons, Association of Women Surgeons, and the Surgical Outcomes Club.
Dr. Maduekwe’s research focuses on health disparities in access to quality surgical oncology care and how that affects disparities in outcome. She has published multiple peer-reviewed articles and book chapters. She is invested in being a resource and mentor to students and residents.
Education and Training
Doctor of Medicine - Harvard Medical School - Boston, MA (2004)
Residency in General Surgery - Massachusetts General Hospital - Boston, MA (2004-2011)
Fellowship in Complex General Surgical Oncology - University of Pittsburgh Medical Center - Pittsburgh, PA (2011-2013)
(Akinkuotu AC, Peace A, Maduekwe UN, Hayes AA.) Am J Surg. 2022 May 26 PMID: 35688671 06/11/2022
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
(Kelly KN, Macedo FI, Seaton M, Wilson G, Hammill C, Martin RC, Maduekwe UN, Kim HJ, Maithel SK, Abbott DE, Ahmad SA, Kooby DA, Merchant NB, Datta J.) Ann Surg Oncol. 2022 May 05 PMID: 35511392 05/06/2022
(Herb J, Maduekwe UN, Goel N, Rosenberger LH, Spanheimer PM.) J Am Coll Surg. 2022 May 01;234(5):774-782 PMID: 35426390 04/16/2022
(Clarke CN, Maduekwe UN.) Ann Surg. 2022 04 01;275(4):e669 PMID: 34913892 SCOPUS ID: 2-s2.0-85126072420 12/17/2021
(Mehtsun WT, McCleary NJ, Maduekwe UN, Wolpin BM, Schrag D, Wang J.) JAMA Oncol. 2022 Jan 01;8(1):88-95 PMID: 34854874 PMCID: PMC8640950 12/03/2021
(Marulanda K, Maduekwe UN.) Surg Oncol Clin N Am. 2022 01;31(1):29-41 PMID: 34776062 11/16/2021
(Portelli Tremont JN, Jadi J, Pham V, Kim HJ, Maduekwe UN.) Am J Surg. 2021 11;222(5):892-896 PMID: 34364656 08/09/2021
(Maduekwe UN, Herb JN, Esther RJ, Kim HJ, Spanheimer PM.) J Surg Oncol. 2021 May;123(8):1792-1800 PMID: 33751586 03/23/2021
(Stewart JH 4th, Blazer DG 3rd, Calderon MJG, Carter TM, Eckhoff A, Al Efishat MA, Fernando DG, Foster JM, Hayes-Jordan A, Johnston FM, Lautz TB, Levine EA, Maduekwe UN, Mangieri CW, Moaven O, Mogal H, Shen P, Votanopoulos KI.) Curr Probl Surg. 2021 04;58(4):100860 PMID: 33832580 04/10/2021
(Akinkuotu AC, Maduekwe UN, Hayes-Jordan A.) Am J Surg. 2021 04;221(4):718-724 PMID: 33678398 03/09/2021
(Carter TM, Strassle PD, Ollila DW, Stitzenberg KB, Meyers MO, Maduekwe UN.) Am J Surg. 2021 04;221(4):706-711 PMID: 33461732 PMCID: PMC8376182 01/20/2021
(Maduekwe UN, Haynes AB.) JAMA Surg. 2021 03 01;156(3):246 PMID: 33326006 12/17/2020